{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:08:14Z","timestamp":1773810494648,"version":"3.50.1"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,12]]},"DOI":"10.1093\/pch\/pxx172","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T01:18:10Z","timestamp":1511831890000},"page":"89-91","source":"Crossref","is-referenced-by-count":5,"title":["Autonomic instability in a dehydrated child on guanfacine: Case report and literature review"],"prefix":"10.1093","volume":"23","author":[{"given":"Elizabeth","family":"Roach-Fox","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital of Western Ontario, London, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Welisch","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Western Ontario, London, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Sarpal","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Western Ontario, London, Ontario"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"key\n\t\t\t\t20180412095405_CIT0001","first-page":"1","volume-title":"Intuniv XR\u00ae Product Monograph","author":"Shire Pharma Canada","year":"2013"},{"key":"key\n\t\t\t\t20180412095405_CIT0002","doi-asserted-by":"crossref","first-page":"40606","DOI":"10.1038\/srep40606","article-title":"A computational psychiatry approach identifies how alpha-2A noradrenergic agonist guanfacine affects feature-based reinforcement learning in the macaque","volume":"7","author":"Hassani","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180412095405_CIT0003","unstructured":"Shojaei AH, Chang R-K, Pennick M . Guanfacine extended release tablets as treatment for attention-deficit\/hyperactivity disorder: Formulation characteristics. Poster presented at the US Psychiatric & Mental Health Congress; New Orleans, Louisiana, November 16\u201319, 2006."},{"key":"key\n\t\t\t\t20180412095405_CIT0004","author":"Canadian ADHD Resource Alliance (CADDRA) Guidelines","year":"2014"},{"key":"key\n\t\t\t\t20180412095405_CIT0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/BF00877397","article-title":"Different types of centrally acting antihypertensives and their targets in the central nervous system","volume":"8","author":"van Zwieten","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"key\n\t\t\t\t20180412095405_CIT0006","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t20180412095405_CIT0007","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","article-title":"A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"121","author":"Biederman","year":"2008","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180412095405_CIT0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CHI.0b013e318191769e","article-title":"Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: A placebo-controlled trial","volume":"48","author":"Sallee","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key\n\t\t\t\t20180412095405_CIT0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cap.2008.0080","article-title":"Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"19","author":"Sallee","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"key\n\t\t\t\t20180412095405_CIT0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1358\/dot.2010.46.5.1450095","article-title":"Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents","volume":"46","author":"Connor","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"key\n\t\t\t\t20180412095405_CIT0011","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/cap.2010.0064","article-title":"Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit\/hyperactivity disorder","volume":"21","author":"Kollins","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"key\n\t\t\t\t20180412095405_CIT0012","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaac.2013.06.006","article-title":"Randomized, double-blind trial of guanfacine extended release in children with attention-deficit\/hyperactivity disorder: Morning or evening administration","volume":"52","author":"Newcorn","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key\n\t\t\t\t20180412095405_CIT0013","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.euroneuro.2014.09.014","article-title":"Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit\/hyperactivity disorder: A randomized, controlled, phase III trial","volume":"24","author":"Hervas","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180412095405_CIT0014","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jaac.2015.08.016","article-title":"A randomized, placebo-controlled trial of guanfacine extended release in adolescents with attention-deficit\/hyperactivity disorder","volume":"54","author":"Wilens","year":"2015","journal-title":"j Am Acad Child Adolesc Psychiatry"},{"key":"key\n\t\t\t\t20180412095405_CIT0015","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-39277-8.00014-2","article-title":"A 19-month-old child with irregular, heavy breathing during sleep","volume-title":"Pediatric Sleep Pearls","author":"Beck","year":"2017"},{"key":"key\n\t\t\t\t20180412095405_CIT0016","author":"Heat stroke","year":"2016"}],"container-title":["Paediatrics &amp; Child Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/pch\/article-pdf\/23\/2\/89\/24610885\/pxx172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T19:26:22Z","timestamp":1570389982000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pch\/article\/23\/2\/89\/4668742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,11,28]]},"published-print":{"date-parts":[[2018,4,12]]}},"URL":"https:\/\/doi.org\/10.1093\/pch\/pxx172","relation":{},"ISSN":["1205-7088","1918-1485"],"issn-type":[{"value":"1205-7088","type":"print"},{"value":"1918-1485","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2017,11,28]]}}}